Related Experiment Videos
Impact of medical genetics concerning phenylketonuria: accomplishments, status and practical future possibilities
1John F. Kennedy Institute, Glostrup, Denmark.
Insights
Newborns are screened for phenylketonuria (PKU) to enable early dietary treatment. PKU management requires lifelong low-phenylalanine diets, especially for women planning pregnancy, with gene mutations identified for carrier detection and potential future gene therapy.
Area of Science:
- Medical Genetics
- Metabolic Disorders
- Biochemistry
Background:
- Phenylketonuria (PKU) is an inherited metabolic disorder requiring early intervention.
- Dietary management, a low-phenylalanine diet, is crucial for preventing intellectual disability in PKU patients.
- PKU management in women requires strict dietary control before and during pregnancy to ensure fetal health.
Purpose of the Study:
- To summarize current strategies for managing phenylketonuria (PKU).
- To highlight the importance of lifelong dietary adherence for PKU patients.
- To explore advancements in PKU diagnostics and potential therapeutic approaches.
Main Methods:
- Newborn screening programs for early PKU detection.
- Lifelong low-phenylalanine dietary management protocols.
- Genetic analysis to identify specific PKU mutations and enable carrier screening.
- In vitro studies using primary hepatocytes for gene therapy research.
Main Results:
- Established identification of two common PKU gene mutations in Denmark, accounting for 60% of cases.
- Oligonucleotide probing facilitates carrier detection and genetic counseling for PKU.
- Successful culture and transformation of primary hepatocytes with phenylalanine hydroxylase cDNA.
Conclusions:
- Early detection and lifelong dietary management are key to preventing PKU complications.
- Genetic advancements enable improved carrier detection and counseling for phenylketonuria.
- Somatic gene therapy using transformed hepatocytes presents a potential future treatment for PKU.
Abstract:
Millions of newborn infants are screened for phenylketonuria (PKU) to prevent the inherited metabolic error by dietary treatment. For some PKU patients a relaxed low-phenylalanine diet will be lifelong. PKU-women must return to a strict low-phenylalanine diet before conception and during pregnancy to insure the delivery of a normal child. Two mutations that account for 60% of the PKU genes in Denmark are established and oligonucleotide probing enables carrier detection and genetic counselling. Primary hepatocytes can be successfully cultured and transformed with phenylalanine hydroxylase cDNA and somatic gene therapy of PKU may be a future possibility.